-
First-in-Man Study of Robotic-Assisted Transcatheter Edge-to-Edge Repair. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-14 Da Zhu,Xiang Chen,Maolong Su,Shouzheng Wang,Wenbin Ouyang,Bin Wang,Xiangbin Pan,Yan Wang
-
Fish and CHIP: Concurrent Percutaneous Left Ventricular Thrombus Retrieval and Complex Coronary Intervention With Hemodynamic Support. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-14 Jonathan X Fang,Zaid Al Jebaje,Khaldoon Alaswad,Gennaro Giustino,James C Lee,Brian P O'Neill,Pedro Engel Gonzalez,Tiberio M Frisoli,Hussayn Alrayes,Leo Kar Lok Lai,Dee Dee Wang,William W O'Neill,Pedro A Villablanca
-
Growing Evidence for Edge-to-Edge Repair in Secondary Mitral Regurgitation: What to Learn From COAPT, MITRA-FR, and RESHAPE-HF2. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-14 Lukas Stolz,Thomas J Stocker,Philipp Lurz,Jörg Hausleiter
-
Surgical Mitral Valve Repair vs Replacement After Failed Mitral Transcatheter Edge-to-Edge Repair: The CUTTING-EDGE Registry. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-14 Mateo Marin-Cuartas,Jagdip Kang,Thilo Noack,Manuela de la Cuesta,Markus Krane,Volkmar Falk,Lenard Conradi,Christian Hagl,Maurizio Taramasso,Tom C Nguyen,D Scott Lim,Gorav Ailawadi,Michael J Mack,Robert L Smith,Anita W Asgar,Kendra J Grubb,Luigi Pirelli,Paolo Denti,Thomas Modine,Michael J Reardon,Tamim M Nazif,Vinayak N Bapat,Tsuyoshi Kaneko,Philipp Kiefer,Michael A Borger,Gilbert H L Tang,Syed Zaid
BACKGROUND The impact of mitral valve (MV) surgery type after failed mitral transcatheter edge-to-edge repair (M-TEER) has not been well studied. OBJECTIVES The aim of this study was to compare the outcomes of MV repair vs replacement after failed M-TEER. METHODS From 2009 to 2020, a total of 332 patients across 34 centers from the CUTTING-EDGE registry underwent MV surgery after M-TEER. Outcomes were
-
Beyond Rescue: The Role of Surgery in Heart Team-Guided Lifetime Management After M-TEER. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-14 Sabine Bleiziffer
-
Cangrelor in Patients With Cardiogenic Shock or Cardiac Arrest. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-14 Fabiana Rollini,Francesco Franchi
-
Cangrelor During Percutaneous Coronary Intervention in Patients With Cardiogenic Shock or Cardiac Arrest. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-14 Oskar Love Emilsson,Moman A Mohammad,Per Grimfjärd,Jonas Persson,Irene Santos-Pardo,David Erlinge,Sasha Koul
BACKGROUND Little is known regarding treatment with cangrelor during percutaneous coronary intervention (PCI) in patients with myocardial infarction complicated by cardiogenic shock or cardiac arrest. OBJECTIVES The aim of this study was to investigate the effects of such cangrelor treatment during PCI in patients with myocardial infarction complicated by cardiogenic shock or cardiac arrest. METHODS
-
Eternal Battle in Multivessel Disease: Is There a Glimmer of Hope for PCI in NSTE-ACS? JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-14 Simone Fezzi,Bruno Scheller
-
Outcomes After CABG Compared With FFR-Guided PCI in Patients Presenting With Acute Coronary Syndrome. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-14 Kuniaki Takahashi,Hisao Otsuki,Frederik M Zimmermann,Victoria Y Ding,Zsolt Piroth,Keith G Oldroyd,Olaf Wendler,Michael J Reardon,Manisha Desai,Y Joseph Woo,Alan C Yeung,Bernard De Bruyne,Nico H J Pijls,William F Fearon,
BACKGROUND There are limited data comparing coronary artery bypass grafting (CABG) with percutaneous coronary intervention (PCI) in patients presenting with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). OBJECTIVES The aim of this study was to evaluate differences in outcomes in patients presenting with or without NSTE-ACS after CABG compared with fractional flow reserve (FFR)-guided
-
Transcatheter Tricuspid Valve Replacement With the Novel System: 1-Year Outcomes From the TRAVEL Study. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-02 Xiangbin Pan,Fanglin Lu,Yiwei Wang,Yingqiang Guo,Mao Chen,Xu Meng,Haibo Zhang,Nianguo Dong,Xiaoke Shang,Jian Yang,Yang Liu,Jianan Wang,Xianbao Liu,Huiming Guo,Jian Liu,Fan Qiao,Guido Ascione,Anson Cheung,Thomas Modine,Ralph Stephan von Bardeleben,Juan F Granada,Zhiyun Xu,Shengshou Hu
BACKGROUND Transcatheter tricuspid valve replacement (TTVR) is emerging as a promising surgical alternative for high-risk patients with tricuspid regurgitation (TR). Nonetheless, the feasibility of more dedicated devices and the need for additional clinical evidence warrant further exploration. OBJECTIVES The purpose of this study was to report the 1-year outcomes of the TRAVEL (Transcatheter Right
-
The Evolving Landscape of TTVR: Embracing the LuXury of Choice. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-01 Neil P Fam,Sami Alnasser
-
Left Main Spontaneous Coronary Artery Dissection: Insights on a Dreadful Presentation. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-04-01 Fernando Alfonso,David Del Val,Teresa Bastante
-
The D Crush: A Simplified Version of the DK Crush for Coronary Bifurcation Stenting. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-31 Sergej Cicovic,Aleksandar Cicovic,Sanjog Kalra,Vladimír Džavík
-
From Cath Lab to C-Suite: Should Interventionalists Get an MBA? JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-28 Mohamad Alkhouli MD MBA
-
Lead-Related Tricuspid Regurgitation: Novel Insights Through the Lens of Computed Tomography. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-28 Davide Margonato,Maurice Enriquez-Sarano,Miho Fukui,Nadira Hamid,Cheng Wang,Ellen Cravero,Asa Phichaphop,Paul Sorajja,Vinayak Bapat,João L Cavalcante
-
Prevalence and Prognostic Value of Subclinical Liver Cirrhosis in Patients Undergoing Transcatheter Tricuspid Valve Replacement. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-28 Alexandru Patrascu,Bryan Traynor,Thomas Attumalil,Mohammed Alkasab,Amr Gamal,Yazeed Almalki,Gianluigi Bisleri,Geraldine Ong,Sami Alnasser,Neil P Fam
-
Platelet-Fibrin Clot Strength for Risk Stratification After PCI in Patients With Diabetes Mellitus: Finding the Sweet Spot. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 Giovanni Occhipinti,Salvatore Brugaletta,Dominick J Angiolillo
-
Early Results of Multicenter Trial of a Novel Balloon-Expandable Valve With Anchor for Aortic Regurgitation. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 Wenzhi Pan,Shasha Chen,Wei Li,Xianbao Liu,Yundai Chen,Jianfang Luo,Xiaogang Guo,Yiqiang Yuan,Ling Tao,Yanqing Wu,Yan Li,Zhihui Zhang,Shenghua Zhou,Zhifu Guo,Xiaofei Jiang,Mingfei Li,Shengda Chen,Jianan Wang,Daxin Zhou,Junbo Ge
BACKGROUND The application of transfemoral transcatheter aortic valve replacement (TAVR) for patients with severe pure native aortic regurgitation (PNAR) is limited by a lack of dedicated devices. The Hanchor Valve system is the first transfemoral balloon-expandable transcatheter heart valve with an anchor element designed for PNAR. OBJECTIVES The aims of this report are to present the 30-day follow-up
-
Different Mechanical Circulatory Support Strategies for Infarct-Related Cardiogenic Shock: A Subanalysis of the ECLS-SHOCK Trial. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 Hans-Josef Feistritzer,Uwe Zeymer,Taoufik Ouarrak,Ibrahim Akin,Tienush Rassaf,Ralf Lehmann,Ingo Eitel,Tim Seidler,Carsten Skurk,Peter Clemmensen,Ingo Voigt,Melchior Seyfarth,Axel Linke,Eike Tigges,Christian Jung,Philipp Lauten,Janine Pöss,Steffen Schneider,Steffen Desch,Anne Freund,Holger Thiele,
BACKGROUND Mechanical circulatory support (MCS) devices are frequently used in patients with acute myocardial infarction complicated by cardiogenic shock. In clinical practice, escalation of MCS device therapy is performed in a significant proportion of patients aiming to improve hemodynamic status. OBJECTIVES The aim of this study was to analyze outcomes of different MCS device strategies in the ECLS-SHOCK
-
Initial Experience and Bench Validation of the CLEVE Prosthetic Leaflet Modification Procedure During Aortic and Mitral Valve-in-Valve Procedures. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 Amar Krishnaswamy,David Meier,Serge Harb,Hacina Gill,Julien Delarive,Althea Lai,Geoffrey Payne,James Yun,Rhonda Miyasaka,Stephanie Sellers,Samir R Kapadia
BACKGROUND Some patients with failing surgical aortic or mitral valves are anatomically unsuitable for typical valve-in-valve procedures due to threatened coronary artery or left ventricular outflow tract obstruction, respectively. OBJECTIVES The authors assessed the clinical and benchtop efficacy of the novel CLEVE (CLEveland Valve Electrosurgery) leaflet modification technique in patients with the
-
Diabetic Status and Thrombogenicity: Association and Prognostic Implications After Percutaneous Coronary Intervention. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 Sungsoo Cho,Moonki Jung,Jong-Hwa Ahn,Min Gyu Kang,Jae Seok Bae,Jin-Sin Koh,Seok-Jae Hwang,Hwi Seung Kim,Sang-Wook Kim,Jin-Yong Hwang,Young-Hoon Jeong
BACKGROUND A heightened prothrombotic environment, combined with premature and more aggressive atherosclerosis, contributes to the elevated cardiovascular risk in patients with diabetes mellitus (DM). OBJECTIVES The aim of this study was to evaluate the association between DM status and thrombogenicity and their prognostic implications in patients with significant coronary artery disease. METHODS A
-
Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation: Expanding Interventional Options. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 Matti Adam,Hendrik Wienemann
-
Cardiogenic Shock: We Didn't Start the Fire. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 David A Baran,Antonio Lewis Camargo
-
TAVR and the Continuous Quest for Improvement. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 Anita W Asgar
-
Tear It Up!: The CLEVE Technique of Intraleaflet Valve Deployment. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 Isida Byku,Robert Lederman,Vasilis Babaliaros
-
Development of a Novel BifurcAID Risk Score to Predict MACE Following Coronary True Bifurcation Intervention. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-24 Shingo Minatoguchi,Anoop N Koshy,Yuliya Vengrenyuk,Manish Vinayak,Keisuke Yasumura,Raman Sharma,Parasuram Krishnamoorthy,Javed Suleman,Joseph Sweeny,Amit Hooda,Vishal Kapur,Roxana Mehran,Samin K Sharma,Annapoorna S Kini
BACKGROUND Percutaneous coronary intervention (PCI) for true bifurcation lesions is associated with a higher risk of adverse clinical events. OBJECTIVES This study sought to establish a point-based score using clinical and angiographic characteristics in true bifurcation lesions before PCI to predict the risk of major adverse cardiovascular events (MACE). METHODS A total of 1,896 consecutive patients
-
Aortic Tortuosity as a Predictor of Surgical Bailout and Adverse Outcomes in TAVR. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-19 Thomas Lohse,Ahmad Hayek,Brahim Harbaoui
-
Understanding 30-Day Out-of-Hospital Mortality After Mitral TEER: Predictors, Challenges, and Opportunities for Improvement JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-19 Vera Fortmeier MD, Tanja K. Rudolph MD
-
High Procedural Efficacy With Transcatheter Tricuspid Annuloplasty by Optimizing Patient Selection and Procedural Approach. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-18 Johannes Kirchner,Muhammed Gerçek,Maria Ivannikova,Felix Rudolph,Hazem Omran,Mohammad Kassar,Tanja K Rudolph,Kai P Friedrichs,Volker Rudolph
-
A Revised Optical Coherence Tomography-Derived Calcium Score to Predict Stent Underexpansion in Severely Calcified Lesions. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-10 Takao Sato,Mitsuaki Matsumura,Kei Yamamoto,Yoichiro Sugizaki,Evan Shlofmitz,Jeffrey W Moses,Omar K Khalique,Susan V Thomas,Sarah Malik,Ali Dakroub,Mandeep Singh,Doosup Shin,David J Cohen,Gary S Mintz,Richard A Shlofmitz,Allen Jeremias,Ziad A Ali,Akiko Maehara
BACKGROUND Severe calcification is the morphology most strongly associated with stent underexpansion. OBJECTIVES The aim of this study was to revise an optical coherence tomography (OCT)-derived calcium score to predict stent underexpansion in severely calcified lesions (angle >270°) using a point-based system. METHODS A retrospective observational study was conducted in which 250 de novo lesions undergoing
-
Fasting vs No Fasting Prior to Percutaneous Cardiovascular Procedures: A Meta-Analysis of Randomized Controlled Trials. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-10 M Haisum Maqsood,Jacqueline E Tamis-Holland,Mamas A Mamas,Davide Capodanno,Deepak L Bhatt,Sripal Bangalore
-
A Journey of Innovation in Mitral Transcatheter Edge-to-Edge Repair: Lessons From the REPAIR Registry. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-10 Gilbert H L Tang,Syed Zaid
-
Call to ACTION: Coronary Calcium Needs Comprehensive Evaluation and Preparation. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-10 Hector M Garcia-Garcia,Jorge Sanz-Sánchez
-
Global Algorithm for the Endovascular Treatment of Chronic Femoropopliteal Lesions: An Interdisciplinary Expert Opinion Statement. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-10 Grigorios Korosoglou,Andrej Schmidt,Michael Lichtenberg,Nasser Malyar,Konstantinos Stavroulakis,Holger Reinecke,Gerd Grözinger,Lorenzo Patrone,Ramon L Varcoe,Peter A Soukas,Dittmar Böckler,Christian-Alexander Behrendt,Eric A Secemsky,Thomas Zeller,Erwin Blessing,Ralf Langhoff,Christos Rammos
A global treatment algorithm was developed for the endovascular revascularization of femoropopliteal lesions and chronic total occlusions, aiming toward a more standardized approach to endovascular treatment in patients with peripheral artery disease. The following steps are proposed. 1) Evaluation of lesion morphology based on preprocedural imaging by Duplex sonography and intravenous ultrasound for
-
Comparison of Stent Geometry Achieved by Different Side-Branch Ballooning Techniques For Bifurcation Provisional Stenting: The CRABBIS Trial JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-10 Francesco Bianchini MD, Enrico Romagnoli MD PhD, Cristina Aurigemma MD PhD, Lazzaro Paraggio MD, Antonino Buffon MD, Francesco Fracassi MD PhD, Mattia Lunardi MD PhD, Luigi Cappannoli MD, Emiliano Bianchini MD, Andrea Zito MD, Carlo Trani MD, Francesco Burzotta MD PhD
Stepwise provisional stenting is the most adopted approach for percutaneous coronary interventions (PCIs) in bifurcation lesions. During these procedures, the side branch (SB) may deserve treatment, but the best ballooning technique is still undetermined.
-
Automated Intravascular Ultrasound Calcium Detection: Derivation and Validation of “The Calcigram” JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-09 Hector M. Garcia-Garcia MD PhD, Kayode Kuku MD, Paulo G.P. Ziemer MSc, Pablo Rubio MD, Carlos A. Bulant DSc, Priti Shah MS, Gary S. Mintz MD, Carlo Di Mario MD PhD, Ron Waksman MD, Pablo J. Blanco DSc
-
Alcohol Septal Ablation Using the Balloon Screen Technique for Severely Angulated Septal Branches. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-06 Nakatsukasa Tomofumi,Hiraya Daigo,Terauchi Taikan,Ishii Yuichiro,Watabe Hiroaki,Hoshi Tomoya,Ishizu Tomoko
-
KISS-POT Method for Proximal Short Segment Bifurcation Stenting: A Modified DK Crush Technique. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-06 Rita-Maria Abdo,Cuneyt Ada
-
Transcatheter Mitral Valve Replacement in Severe Mitral Annular Calcification: BATMAN and ROBIN, the Dynamic Duo JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-05 Sami Alnasser MD, Thomas Attumalil MD, Mohammed Alkasab MD, Alex Patrascu MD PhD, Yazeed Almalki MD, Geraldine Ong MD MSc, David Latter MD, Neil P. Fam MD MSc
-
Sex Differences in HBR-PCI With Abbreviated DAPT: Keep it Short and Sweet JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-05 Jaya Chandrasekhar MBBS MS PhD
-
Residual Mitral Regurgitation Predicts Survival Independent of Mitral Valve Pressure Gradient Following Transcatheter Edge-to-Edge Repair JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-05 Dennis Rottländer MD, Jörg Hausleiter MD, Thomas Schmitz MD, Alexander Bufe MD, Melchior Seyfarth MD, Ralph Stephan von Bardeleben MD, Harald Beucher MD, Taoufik Ouarrak MSc, Steffen Schneider PhD, Peter Boekstegers MD, the MITRA-PRO Investigators
-
Instantaneous Wave-Free Ratio Monitoring of an Anomalous Left Coronary During Self-Expanding Transcatheter Pulmonary Valve Implantation JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-05 Conor P. O’Halloran MD, Kaitlin Swanson MD, Keegan Marz DNP FNP-BC, Farshad Sedaghat-Yazdi MD, Paul Tannous MD PhD
-
Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease: 1-Year Results From EXPANDed JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-05 Saibal Kar MD, Matthew J. Price MD, M. Andrew Morse MD, Michael J. Rinaldi MD, Paul Mahoney MD, Paolo Denti MD, Federico M. Asch MD, Jose L. Zamorano MD, Janani Aiyer MS, Rong Huang MS, Francesco Maisano MD, Ralph Stephan von Bardeleben MD PhD, Evelio Rodriguez MD
Treating anterior and bileaflet mitral valve disease in patients with primary or degenerative mitral regurgitation (DMR) is considered more challenging than posterior leaflet repair.
-
Catastrophic Migration of the Axillary IABP Into the Right Renal Artery JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-05 Manish Vinayak MD, Gregory Serrao MD, Ajit Rao MD, Johanna Contreras MD, Samin K. Sharma MD, Annapoorna S. Kini MD, Prakash Krishnan MD, Umesh Gidwani MD, Anelechi Anyanwu MD, George D. Dangas MD PhD
-
Anterior, Posterior, or Bileaflet Mitral Valve Pathology: No Reason to Worry With M-TEER! JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-05 Thomas J. Stocker MD, Jörg Hausleiter MD
-
Transcatheter Pulmonary Valve Implantation Using Self-Expandable Percutaneous Pulmonary Valve System: 3-Year CE Study Results. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-03-01 Shakeel A Qureshi,Matthew I Jones,Kuberan Pushparajah,Jou-Kou Wang,Damien Kenny,Kevin Walsh,Younes Boudjemline,Worakan Promphan,Pimpak Prachasilchai,John Thomson,James R Bentham,Felix Berger,Carlos A C Pedra,Marc Gewillig,Bryan P Yan,Ziyad M Hijazi
BACKGROUND Pulmonary regurgitation is common during follow-up of patients after surgical repair of tetralogy of Fallot and other right ventricular outflow tracts (RVOTs). Many percutaneous pulmonary valves have been used but are limited to smaller RVOTs. OBJECTIVES Since August 2016, a multicenter CE (Conformité Européenne) study was initiated to evaluate a self-expandable VenusP-valve. We aimed to
-
Percutaneous Coronary Treatment With Bioadaptor Implant vs Drug-Eluting Stent: 2-Year Outcomes From BIOADAPTOR RCT JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-26 Shigeru Saito MD, Johan Bennett MD PhD, Holger M. Nef MD PhD, Mark Webster MD, Atsuo Namiki MD, Akihiko Takahashi MD PhD, Tsunekazu Kakuta MD, Seiji Yamazaki MD, Yoshisato Shibata MD, Douglas Scott MD, Mathias Vrolix MD, Madhav Menon MD, Helge Möllmann MD PhD, Nikos Werner MD PhD, Antoinette Neylon MD, Zlatko Mehmedbegovic MD, Pieter C. Smits MD PhD, Marie-Claude Morice MD, Stefan Verheye MD PhD, BIOADAPTOR-RCT
The sirolimus-eluting bioadaptor is a novel coronary implant that unlocks, separates, and maintains dynamic support of the vessel at the lesion site 6 months after percutaneous coronary intervention when the polymer coating covering the helical strands resorbs. This enables the bioadaptor to maintain the established flow lumen and to restore hemodynamic modulation of the artery, including cyclic pulsatility
-
Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-25 Michele Morosato,Carlo Gaspardone,Davide Romagnolo,Matteo Pagnesi,Luca Baldetti,Sara Dormio,Francesco Federico,Anna Mara Scandroglio,Alaide Chieffo,Cosmo Godino,Alberto Margonato,Marianna Adamo,Marco Metra,Didier Tchetche,Nicolas Dumonteil,Marysia S Tweet,Jacqueline Saw,Alessandro Beneduce
BACKGROUND Spontaneous coronary artery dissection (SCAD) is an uncommon cause of acute myocardial infarction (MI) and is associated with substantial adverse events. SCAD involving the left main coronary artery (LM) is a rare but potentially life-threatening condition. Currently, minimal data on LM SCAD have been reported. OBJECTIVES The aim of this study was to investigate clinical features, contemporary
-
Out-of-Hospital 30-Day Mortality After Mitral TEER: Insights From the STS/ACC TVT Registry JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-25 Kannu Bansal MD, Bharat Rawlley MD, Vidit Majmundar MD, Robert Beale MD, Miloni Shah MPH, Andrzej S. Kosinski PhD, Tanush Gupta MD, Fahad Gilani MD, Saif Anwaruddin MD, Sahil Khera MD MPH, Sreekanth Vemulapalli MD, Sammy Elmariah MD MPH, Dhaval Kolte MD PhD MPH
Transcatheter edge-to-edge repair of mitral valve (mTEER) is increasingly being adopted, with improved outcomes. However, it remains crucial to evaluate short-term out-of-hospital mortality to elucidate areas for further improvement.
-
How Procedural Volume Prerequisites Could Impact Access to Tricuspid Transcatheter Edge-to-Edge Repair. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Sreekanth Vemulapalli,Julie B Prillinger,David H Adams
-
Transesophageal Echocardiography Guidance Is Useful for Valve-in-Valve Transcatheter Aortic Valve Replacement. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Lior Henri Fortis,Akshat Khurana,Yoav Niv Granot,Lori B Croft,Amit Hooda,Sahil Khera,Francesca Romana Prandi,Gilbert H L Tang,Samin K Sharma,Annapoorna Kini,Stamatios Lerakis
-
A Decade of Follow-Up by the DECADE Cooperation: A Final "Nail in the Coffin" of the Outdated "Smoker's Paradox"? JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Michael A Kutcher
-
Partial Dyscoaptation of SAPIEN 3 Ultra RESILIA Treated by Post-Ballooning During Transcatheter Aortic Valve Replacement. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Takahide Sano,Mike Saji,Kojiro Sakurai,Kota Kawada,Hideo Amano,Takeshiro Fujii
-
Embolic Protection Device Use With Transcatheter Aortic Valve Replacement After PROTECTED TAVR Trial. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Marwan Saad,Phinnara Has,Ahmed Elkaryoni,Mohamad Alkhouli
-
Coronary Endothelial Function: A Novel Acetylcholine Infusion Protocol With Continuous Thermodilution. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Abdalla Ibrahim,Samer Fawaz,Uzma Sajjad,Carlos Collet,Bernard De Bruyne,Divaka Perera,John R Davies,Thomas R Keeble,Kevin Carson,Klio Konstantinou
-
Beyond Echo-Derived Gradients: Balloon-Expandable Valve Outcomes in Small Annuli Patients. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Amit N Vora,John K Forrest,Amar Krishnaswamy
-
Unveiling the Invisible: The Impact of 3D Intracardiac Echocardiography on Mitral Transcatheter Edge-to-Edge Repair. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Scott Dougherty,Fei Yu,Chenxu Zhao,Martin Wong,Geri Wong,Kent So,Kevin Kam,Yiting Fan,Alex Pui Wai Lee
-
Percutaneous Release of Thrombosed Mechanical Mitral Valve Leaflet: Aspirate and Liberate. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Carlos Vergara Sanchez,Nahyr Lugo-Fagundo,Mays Ali,Jordan Ray,Prajwal Reddy,Michael S Gharacholou,Abdallah El Sabbagh
-
Can a SWEDEHEART Win Over the FLAIR Crew and End the iFR/FFR Debate? JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Arnold H Seto,Gautam Kumar
-
Real-Time Echocardiographic Morphology of Transcatheter Closure of Patent Foramen Ovale With Different Occluders. JACC Cardiovasc. Inte. (IF 11.7) Pub Date : 2025-02-24 Kun Wang,Zheng Li,Yuan Yao,Xiao-Mei Gao,Xiao-Fei Jiang